CCCC

C4 Therapeutics (CCCC)

C4 Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CCCC

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	20:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CCCC	C4 Therapeutics Inc
2024/05/08	20:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CCCC	C4 Therapeutics Inc
2024/05/08	20:00	GlobeNewswire Inc.	C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:CCCC	C4 Therapeutics Inc
2024/04/30	05:01	GlobeNewswire Inc.	C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:CCCC	C4 Therapeutics Inc
2024/04/09	20:00	GlobeNewswire Inc.	C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum	NASDAQ:CCCC	C4 Therapeutics Inc
2024/04/08	21:00	GlobeNewswire Inc.	C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024	NASDAQ:CCCC	C4 Therapeutics Inc
2024/03/09	09:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/03/09	09:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/03/09	09:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/03/09	09:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/03/09	09:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/03/09	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CCCC	C4 Therapeutics Inc
2024/03/06	06:30	GlobeNewswire Inc.	C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024	NASDAQ:CCCC	C4 Therapeutics Inc
2024/03/04	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CCCC	C4 Therapeutics Inc
2024/03/04	21:00	GlobeNewswire Inc.	C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/22	23:01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/22	21:20	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/22	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/22	21:00	GlobeNewswire Inc.	C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/16	07:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/16	07:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/16	07:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/16	07:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/16	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/14	23:21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/06	00:24	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CCCC	C4 Therapeutics Inc
2024/02/02	23:34	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CCCC	C4 Therapeutics Inc
2024/01/13	06:01	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CCCC	C4 Therapeutics Inc
2024/01/11	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CCCC	C4 Therapeutics Inc
2024/01/10	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CCCC	C4 Therapeutics Inc